Related Experiment Videos
Single enhancing computerized tomography-detected lesion in immunocompetent patients
1Department Of Neurology, King George's Medical College, Lucknow, India. garg50@yahoo.com
Neurosurgical Focus
|June 2, 2005
Summary
Single enhancing brain lesions, often seen with seizures in developing countries, are most commonly neurocysticercosis (NCC). These lesions typically resolve spontaneously, aiding diagnosis and guiding treatment with antiepileptic drugs.
Area of Science:
- Neurology
- Radiology
- Infectious Diseases
Background:
- Single enhancing brain lesions on CT scans are common in acute-onset seizures, particularly in developing countries.
- These lesions are often attributed to neoplasms or tuberculoma in developed nations, but neurocysticercosis (NCC) is frequently the underlying cause.
- Differentiating between NCC and tuberculoma can be challenging due to overlapping clinical and imaging features.
Purpose of the Study:
- To investigate the etiology and diagnostic criteria for single enhancing brain lesions.
- To evaluate the natural course and management of these lesions, particularly in the context of neurocysticercosis.
Main Methods:
- Review of clinical and radiological findings in patients with single enhancing brain lesions.
- Histopathological correlation where available.
- Analysis of lesion resolution patterns on serial CT scans.
Main Results:
- Neurocysticercosis (NCC) is the most probable cause of single enhancing lesions (<20 mm, minimal edema) in patients with seizures and normal neurological status.
- Lesions often resolve spontaneously, either disappearing or becoming calcified, supporting an NCC diagnosis.
- Tuberculoma is the second most common cause, presenting similar features, making differentiation difficult in endemic areas.
Conclusions:
- Single enhancing brain lesions in seizure patients are frequently due to NCC, especially when they resolve spontaneously.
- Antiepileptic therapy is the mainstay of treatment; anticysticercal drugs have uncertain benefit.
- Brain biopsy is rarely needed, reserved for refractory cases or diagnostic uncertainty.